Igene Biotechnology, Inc. (IGNE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2009 | 2008 | 2007 | 2006 | 2003 | 2002 |
|---|---|---|---|---|---|---|
| Revenue | 3.95 Million | 7.64 Million | 2.28 Million | - | 463.48 Thousand | 3.49 Million |
| Cost of Revenue | 2.94 Million | 6.39 Million | 1.68 Million | - | 446.14 Thousand | 3.16 Million |
| Gross Profit | 1.01 Million | 1.24 Million | 605.09 Thousand | - | 17.34 Thousand | 324.13 Thousand |
| Operating Expenses | 990.93 Thousand | 3.43 Million | 537.97 Thousand | 307.37 Thousand | 642.08 Thousand | 2.17 Million |
| Selling, General and Administrative Expenses | 1.22 Million | 1.78 Million | 1.13 Million | 1.12 Million | 1.01 Million | 1.51 Million |
| Research and Development Expenses | 1.85 Million | 1.65 Million | 983.61 Thousand | 847.59 Thousand | 745.36 Thousand | 609.78 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 3.93 Million | 9.83 Million | 2.21 Million | 307.37 Thousand | 1.08 Million | 5.34 Million |
| Operating Income | -1.06 Million | -2.18 Million | 237.94 Thousand | -416.51 Thousand | -624.74 Thousand | -1.85 Million |
| Interest Expense | 97.52 Thousand | 2.02 Million | 2.16 Million | 753.79 Thousand | 897.54 Thousand | 903.36 Thousand |
| Income Tax Expense | 165.38 Thousand | 1.8 Million | 1.96 Million | 848.4 Thousand | 659.9 Thousand | 1.33 Million |
| Earnings before Tax | -43.22 Thousand | -1.96 Million | 261.56 Thousand | -401.98 Thousand | -420.13 Thousand | -2.75 Million |
| Net Income | -140.74 Thousand | -3.99 Million | -1.89 Million | -1.15 Million | -2.19 Million | -3.18 Million |
| Earnings Per Share Basic | -0.00 | -0.02 | -0.02 | -0.01 | -0.02 | -0.04 |
| Earnings Per Share Diluted | -0.00 | -0.02 | -0.02 | -0.01 | -0.02 | -0.04 |
| Weighted Average Shares Outstanding | 1.53 Billion | 187.03 Million | 109.67 Million | 108.38 Million | 90.43 Million | 81.54 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.53 Billion | 187.03 Million | 109.67 Million | 108.38 Million | 90.43 Million | 81.54 Million |
| Gross Margin | 0.26 | 0.16 | 0.26 | - | 0.04 | 0.09 |
| EBIT Margin | -0.22 | -0.30 | 0.02 | - | -3.58 | -0.47 |
| Profit Margin | -0.04 | -0.52 | -0.83 | - | -4.74 | -0.91 |
| EBITDA | -851.28 Thousand | -2.08 Million | 324.57 Thousand | -307.51 Thousand | -540.95 Thousand | -1.67 Million |
| Earnings Before Tax Margin | -0.27 | -0.29 | 0.10 | - | -1.35 | -0.53 |
| Breakdown | 2010 Q3 | 2010 Q2 | 2010 Q1 | 2009 FY | 2009 Q4 | 2009 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 3.95 Million | 4804.00 | 1.11 Million |
| Cost of Revenue | - | - | - | 2.94 Million | -36.04 Thousand | 461.47 Thousand |
| Gross Profit | - | - | - | 1.01 Million | 40.84 Thousand | 654.31 Thousand |
| Operating Expenses | 95.44 Thousand | 126.63 Thousand | 147.59 Thousand | 990.93 Thousand | 267.94 Thousand | 82.76 Thousand |
| Selling, General and Administrative Expenses | 141.52 Thousand | 295.61 Thousand | 208.85 Thousand | - | 297.58 Thousand | 259.85 Thousand |
| Research and Development Expenses | 527.64 Thousand | 513.09 Thousand | 469.71 Thousand | - | 530.26 Thousand | 442.33 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 95.44 Thousand | 126.63 Thousand | 147.59 Thousand | 3.93 Million | 231.9 Thousand | 544.23 Thousand |
| Operating Income | -625.5 Thousand | -822.06 Thousand | -540.88 Thousand | -1.06 Million | -343.17 Thousand | 151.21 Thousand |
| Interest Expense | 10.23 Thousand | 2935.00 | 8166.00 | 97.52 Thousand | 43.21 Thousand | 36.4 Thousand |
| Income Tax Expense | 531.79 Thousand | 684.58 Thousand | 401.44 Thousand | 165.38 Thousand | 159.29 Thousand | 456.74 Thousand |
| Earnings before Tax | -617 Thousand | -808.27 Thousand | - | -43.22 Thousand | - | - |
| Net Income | -627.23 Thousand | -811.21 Thousand | -549.04 Thousand | -140.74 Thousand | -386.38 Thousand | 114.8 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | - | 0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | - | 0.00 |
| Weighted Average Shares Outstanding | 1.56 Billion | 1.56 Billion | 1.56 Billion | 1.53 Billion | - | 1.55 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.56 Billion | 1.56 Billion | 1.56 Billion | 1.53 Billion | - | 1.55 Billion |
| Gross Margin | - | - | - | 0.26 | 8.50 | 0.59 |
| EBIT Margin | - | - | - | - | -41.87 | 0.55 |
| Profit Margin | - | - | - | -0.04 | -80.43 | 0.10 |
| EBITDA | -66.26 Thousand | -102.74 Thousand | -109.91 Thousand | - | -201.14 Thousand | 612.67 Thousand |
| Earnings Before Tax Margin | - | - | - | -0.27 | -71.43 | 0.14 |
002389
FUPBY
ML
002955
TITAGARH
NIND